| # | Drug | Count |
|---|---|---|
| 0 | CERTOLIZUMAB PEGOL | 33 |
| 1 | MEPOLIZUMAB | 30 |
| 2 | ALBUTEROL SULFATE | 18 |
| 3 | MONTELUKAST SODIUM | 14 |
| 4 | PREDNISONE | 13 |
| 5 | BELIMUMAB | 10 |
| 6 | TIOTROPIUM BROMIDE | 10 |
| 7 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 9 |
| 8 | DUPILUMAB | 9 |
| 9 | IPRATROPIUM BROMIDE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 1 | 0.0025 |
| 1 | BUROSUMAB | 7 | 0.0011 |
| 2 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 3 | PSYLLIUM HUSK | 1 | 0.0007 |
| 4 | MEPOLIZUMAB | 30 | 0.0006 |
| 5 | LARONIDASE | 2 | 0.0005 |
| 6 | METHYLCELLULOSE | 1 | 0.0004 |
| 7 | AGALSIDASE BETA | 4 | 0.0004 |
| 8 | RILPIVIRINE | 3 | 0.0004 |
| 9 | PILOCARPINE HYDROCHLORIDE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 30 | 0.0436 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 4 | 0.0004 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 10 | 0.0003 |
| 4 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 6 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 3 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | Leukotriene Receptor Antagonist [EPC] | 2 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |